NEW YORK (AP) — NEW YORK (AP) — Seelos Therapeutics, Inc. (SEEL) on Tuesday reported profit of $10.5 million in its third quarter.
On a per-share basis, the New York-based company said it had net loss of 12 cents. Losses, adjusted for non-recurring gains, were 28 cents per share.
The drugmaker posted revenue of $406,000 in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SEEL at https://www.zacks.com/ap/SEEL